Skip to content

CAT Score and Airway Limitation in Adult Smokers

Relationship Between CAT Score and Airway Limitation in Adult Smokers

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06644456
Acronym
CAT
Enrollment
90
Registered
2024-10-16
Start date
2024-08-01
Completion date
2025-03-10
Last updated
2026-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smokers

Keywords

smoker, CAT

Brief summary

This study aimed to show the relationship between CAT Score and airway limitation in smokers who applied to MSKU Chest Diseases Polyclinic with respiratory complaints (shortness of breath, cough, sputum, etc.) and underwent respiratory function tests. CAT Score is a measurement used to evaluate the quality of life of Chronic Obstructive Pulmonary Disease (COPD) patients. CAT Score is a scale used to assess patients' symptoms (such as shortness of breath, cough, and sputum) and problems affecting their daily activities. CAT Score usually takes a value between 0 and 40, and a high score may indicate that the patient's quality of life is low. There are studies on the usability of CAT Score in Bronchiectasis, Tuberculosis, and Asthma Diseases other than COPD. We hypothesize that there is a positive correlation between CAT Score and airway limitation in smokers before COPD develops. The study was planned as cross-sectional. Between July 2024 and December 2024, patients who apply to MSKU Chest Diseases Polyclinic with respiratory complaints and have a history of smoking will have their CAT scores, 6-minute walking test, and height and weight measurements performed and recorded. In our study, the comparison of CAT Scores of individuals who smoke and have normal respiratory function test parameters with those who are not normal but excluded from COPD is planned as the primary endpoint, and comparisons of CAT Scores with exercise capacities and body mass indexes are planned as the secondary endpoint.

Interventions

None listed

Sponsors

Muğla Sıtkı Koçman University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Smoking history Being over 18 years old Being symptomatic

Exclusion criteria

* Having a diagnosis of chronic respiratory disease (COPD, Asthma, IPF)

Design outcomes

Primary

MeasureTime frameDescription
CATday 1In our study, the primary endpoint was to compare the CAT scores of individuals who smoked and had normal pulmonary function test parameters with those who were not normal but excluded from COPD.

Secondary

MeasureTime frameDescription
6MWT-BMIday 1Comparisons of exercise capacities and body mass indexes with CAT Scores are planned as secondary endpoints. Weight and height will be combined to report BMI in kg/m\^2. 6mwt distance will be reported as meter

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 15, 2026